BOOTS COMPANY PLC

1 Thane Road West, Beeston, Nottingham, NG2 3AA
Telephone: +44 (0)1159 595 306
Fax: +44 (0)1159 592 565


Summary of Product Characteristics last updated on the eMC: 21/09/2009
SPC Haemorrhoid Relief Ointment


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Boots Haemorrhoid Ointment or Haemorrhoid Relief Ointment


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active ingredients

% w/w

Specification

Lidocaine

0.6

Ph Eur

Zinc oxide

6.6

Ph Eur


Go to top of the page
3. PHARMACEUTICAL FORM

Rectal ointment.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

This product is indicated for the relief of pain and discomfort of haemorrhoids and pruritis ani.


Go to top of the page
4.2 Posology and method of administration

HAEMORRHOIDS

Adults, children over 12 years and elderly: This product should be applied night and morning and after each bowel movement. Repeat as required.

EXTERNAL PILES

Moisten cotton wool with warm water and gently cleanse the sore area. Carefully dry with fresh cotton wool and apply approximately 1 inch (2.5 cm) of this product.

INTERNAL PILES

Remove cap of tube. Screw the nozzle supplied to the top of the tube. Apply a little ointment to the outside of the nozzle for greater comfort. Insert nozzle into anal opening and gently squeeze ointment inside. This is easier to do if you bend forward.

PRURITIS ANI

Adults, children over 12 years and elderly: This product should be applied when required.


Go to top of the page
4.3 Contraindications

Hypersensitivity to any of the ingredients, especially lidocaine.


Go to top of the page
4.4 Special warnings and precautions for use

Do not use if you are sensitive to any of the ingredients.

Keep all medicines out of the reach of children.

For external use only.

Constipation should be avoided as it may aggravate the symptoms. For further advice consult your pharmacist.

If symptoms persist for more than 14 days talk to your doctor.

Not recommended for pregnant women or children under the age of 12 years except on medical advice.

Side effects are rare with this medication but if anything unusual happens seek medical advice.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

No clinically significant interactions are known.


Go to top of the page
4.6 Pregnancy and lactation

The safety of this product in pregnancy and lactation has not been established, but is not thought to constitute a hazard, though caution should be exercised during the first trimester.


Go to top of the page
4.7 Effects on ability to drive and use machines

None.


Go to top of the page
4.8 Undesirable effects

Hypersensitivity reactions to any of the ingredients, particularly lidocaine. Occasionally may cause diarrhoea.


Go to top of the page
4.9 Overdose

In view of the nature of the presentation of this product, accidental or deliberate overdosage is highly unlikely. In the event of overdosage, this will initially produce excessive anaesthesia of the upper gastrointestinal tract. Treatment of potential overdosage should be symptomatic and supportive.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Lidocaine has a local anaesthetic action, which relieves pain and discomfort in the affected areas. Zinc oxide applied externally has a mild astringent action on the skin.


Go to top of the page
5.2 Pharmacokinetic properties

Lidocaine is readily absorbed from mucous membranes. The plasma elimination half-life is about two hours.

Lidocaine undergoes significant first pass metabolism in the liver and is rapidly de-ethylated to the active metabolite monoethylglycine-xylidide and then hydrolysed to various metabolites including glycine xylidide. Less than 10% is excreted unchanged in the kidneys. The metabolites are also excreted in the urine.


Go to top of the page
5.3 Preclinical safety data

Not applicable.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Yellow soft paraffin

Light liquid paraffin

Colloidal anhydrous silica


Go to top of the page
6.2 Incompatibilities

Not applicable.


Go to top of the page
6.3 Shelf life

36 months, northern temperate regions.


Go to top of the page
6.4 Special precautions for storage

None.


Go to top of the page
6.5 Nature and contents of container

An internally lacquered aluminium tube with a gasket and a polyethylene or polypropylene screw cap. The pack is supplied with a screw-on rectal applicator.

Pack sizes: 25g, 55g


Go to top of the page
6.6 Special precautions for disposal and other handling

EXTERNAL PILES

Moisten cotton wool with warm water and gently cleanse the sore area. Carefully dry with fresh cotton wool and apply approximately 1 inch (2.5 cm) of this product.

INTERNAL PILES

Remove cap of tube. Screw the nozzle supplied to the top of the tube. Apply a little ointment to the outside of the nozzle for greater comfort. Insert nozzle into anal opening and gently squeeze ointment inside. This is easier to do if you bend forward.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

The Boots Company PLC

1 Thane Road West

Nottingham NG2 3AA


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 00014/0448


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

Date of first authorisation: 11 May 1995


Go to top of the page
10. DATE OF REVISION OF THE TEXT

June 2009



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/11194/SPC/


Active Ingredients/Generics

 
   zinc oxide
   lidocaine